Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | n/a | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | n/a | n/a |
Pr/Book | 2.7 |
Latest | F'cast | |
---|---|---|
Revenue | n/a | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | n/a | (2.53) | (0.19)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | n/a | (3.52) | (0.22)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | n/a | (2.68) | (0.16)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | n/a | (3.45) | (0.20)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-24 | n/a | (4.43) | (0.22)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Encouraging results in second batch of assays | 30-Apr-2025 | 07:00 | RNS |
Investor Presentation | 23-Apr-2025 | 07:00 | RNS |
Holding(s) in Company | 22-Apr-2025 | 08:47 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 4.78p |
Change Today | -0.025p |
% Change | -0.52 % |
52 Week High | 5.55 |
52 Week Low | 3.20 |
Volume | 1,613,960 |
Shares Issued | 2,172.77m |
Market Cap | £103.75m |
Beta | 0.01 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
14:27 | 500,000 @ 4.78p |
14:26 | 414,851 @ 4.82p |
14:18 | 30,866 @ 4.82p |
14:00 | 10,000 @ 4.83p |
13:47 | 8,000 @ 4.83p |
CEO | Emanuel Proença |
Chair | Rick Anthon |
You are here: research